Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act, 30063-30064 [2021-11786]

Download as PDF Federal Register / Vol. 86, No. 106 / Friday, June 4, 2021 / Notices the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Date: June 14, 2021. Open: 11:00 a.m. to 12:00 p.m. Agenda: NCAB Subcommittee Meetings— Subcommittee on Planning and Budget. Open: 12:05 p.m. to 4:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Director’s report and presentations. Closed: 4:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Date: June 15, 2021. Open: 1:00 p.m. to 3:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Board of Scientific Advisors Concepts Review, Ongoing and New Business. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Contact Person: Paulette S. Gray, Ph.D. Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room. 7W444, Bethesda, MD 20892, 240–276–6340, grayp@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: NCAB: https://deainfo.nci.nih.gov/ advisory/ncab/ncabmeetings.htm, BSA: https://deainfo.nci.nih.gov/advisory/ bsa/bsameetings.htm, where an agenda and any additional information for the meeting will be posted when available. This notice is being published less than 15 days prior to the meeting due to scheduling difficulties. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) VerDate Sep<11>2014 17:08 Jun 03, 2021 Jkt 253001 Dated: June 1, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–11783 Filed 6–3–21; 8:45 am] 30063 DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency BILLING CODE 4140–01–P [Docket ID FEMA–2020–0016] DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, National Cancer Institute. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, National Cancer Institute. Date: July 12–13, 2021. Time: 11:00 a.m. to 5:30 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Contact Person: Brian E. Wojcik, Ph.D., Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W414, Rockville, MD 20850, 240–276–5660, wojcikb@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: June 1, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–11784 Filed 6–3–21; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Federal Emergency Management Agency, Department of Homeland Security. ACTION: Announcement of meetings. AGENCY: The Federal Emergency Management Agency (FEMA) held two meetings to implement the Voluntary Agreement for the Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic. DATES: The first meeting took place on Tuesday, May 25, 2021, from 10:30 a.m. to 12 p.m. Eastern Time (ET). The second meeting took place on Wednesday, May 26, 2021, from 2 to 3 p.m. ET. FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, Industry, Infrastructure Integration, via email at OB3I@fema.dhs.gov or via phone at (202) 212–1666. SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as required by section 708(h)(8) of the Defense Production Act (DPA), 50 U.S.C. 4558(h)(8), and consistent with 44 CFR part 332. The DPA authorizes the making of ‘‘voluntary agreements and plans of action’’ with representatives of industry, business, and other interests to help provide for the national defense.1 The President’s authority to facilitate voluntary agreements with respect to responding to the spread of COVID–19 within the United States was delegated to the Secretary of Homeland Security in Executive Order 13911.2 The Secretary of Homeland Security further delegated this authority to the FEMA Administrator.3 On August 17, 2020, after the appropriate consultations with the Attorney General and the Chairman of the Federal Trade Commission, FEMA completed and published in the Federal Register a ‘‘Voluntary Agreement, Manufacture and Distribution of Critical Healthcare Resources Necessary to SUMMARY: 1 50 U.S.C. 4558(c)(1). FR 18403 (Apr. 1, 2020). 3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS Delegation Number 09052 Rev. 00 (Jan. 3, 2017). 2 85 E:\FR\FM\04JNN1.SGM 04JNN1 30064 Federal Register / Vol. 86, No. 106 / Friday, June 4, 2021 / Notices Respond to a Pandemic’’ (Voluntary Agreement).4 Unless terminated earlier, the Voluntary Agreement is effective until August 17, 2025, and may be extended subject to additional approval by the Attorney General after consultation with the Chairman of the Federal Trade Commission. The Agreement may be used to prepare for or respond to any pandemic, including COVID–19, during that time. On December 7, 2020, the first plan of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Personal Protective Equipment (PPE) to Respond to COVID– 19 (Plan of Action)—was finalized.5 The Plan of Action established several subcommittees under the Voluntary Agreement, focusing on different aspects of the Plan of Action. The meetings were chaired by the FEMA Administrator or her delegate and attended by the Attorney General and the Chairman of the Federal Trade Commission or their delegates. In implementing the Voluntary Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 4558 and 44 CFR part 332. Meeting Objectives: The objectives of the meetings were as follows: 1. Gather committee Participants and Attendees to ask targeted questions for situational awareness about PPE, drug products and drug substances, diagnostic test kits, medical devices, and medical gases. 2. Establish priorities for COVID–19 response under the Voluntary Agreement. 3. Identify tasks that should be completed under the appropriate SubCommittee. 4. Identify information gaps and areas that merit sharing (both from FEMA to the private sector and vice versa). Meetings Closed to the Public: By default, the DPA requires meetings held to implement a voluntary agreement or plan of action be open to the public.6 However, attendance may be limited if the Sponsor 7 of the voluntary 4 85 FR 50035 (Aug. 17, 2020). The Attorney General, in consultation with the Chairman of the Federal Trade Commission, made the required finding that the purpose of the voluntary agreement may not reasonably be achieved through an agreement having less anticompetitive effects or without any voluntary agreement and published the finding in the Federal Register on the same day. 85 FR 50049 (Aug. 17, 2020). 5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 8, 2020). 6 See 50 U.S.C. 4558(h)(7). 7 ‘‘[T]he individual designated by the President in subsection (c)(2) [of section 708 of the DPA] to administer the voluntary agreement, or plan of action.’’ 50 U.S.C. 4558(h)(7). VerDate Sep<11>2014 17:08 Jun 03, 2021 Jkt 253001 agreement finds that the matter to be discussed at a meeting falls within the purview of matters described in 5 U.S.C. 552b(c), such as trade secrets and commercial or financial information. The Sponsor of the Voluntary Agreement, the FEMA Administrator, found that these meetings to implement the Voluntary Agreement involved matters which fall within the purview of matters described in 5 U.S.C. 552b(c) and the meetings were therefore closed to the public. Specifically, these meetings to implement the Voluntary Agreement may have required participants to disclose trade secrets or commercial or financial information that is privileged or confidential. Disclosure of such information allows for meetings to be closed pursuant to 5 U.S.C. 552b(c)(4). In addition, the success of the Voluntary Agreement depends wholly on the willing and enthusiastic participation of private sector participants. Failure to close these meetings could have had a strong chilling effect on private sector participation and caused a substantial risk that sensitive information would be prematurely released to the public, leading to participants withdrawing their support from the Voluntary Agreement. This would have significantly frustrated the implementation of the Voluntary Agreement. Frustration of an agency’s objective due to premature disclosure of information allows for the closure of a meeting pursuant to 5 U.S.C. 552b(c)(9)(B). Deanne Criswell, Administrator, Federal Emergency Management Agency. [FR Doc. 2021–11786 Filed 6–3–21; 8:45 am] BILLING CODE 9111–19–P DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration Intent To Request a Revision From OMB of One Current Public Collection of Information: Department of Homeland Security Traveler Redress Inquiry Program (DHS TRIP) Transportation Security Administration, Homeland Security (DHS). ACTION: 60-Day notice. AGENCY: The Transportation Security Administration (TSA) invites public comment on one currently approved Information Collection Request (ICR), Office of Management and Budget (OMB) control number 1652–0044, SUMMARY: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 abstracted below that we will submit to OMB for a revision in compliance with the Paperwork Reduction Act (PRA). The ICR describes the nature of the information collection and its expected burden. The collection involves the submission of identifying the travel experience information submitted by individuals requesting redress through the Department of Homeland Security (DHS) Traveler Redress Inquiry Program (TRIP). DATES: Send your comments by August 3, 2021. ADDRESSES: Comments may be emailed to TSAPRA@tsa.dhs.gov or delivered to the TSA PRA Officer, Information Technology, TSA–11, Transportation Security Administration, 6595 Springfield Center Drive, Springfield, VA 20598–6011. FOR FURTHER INFORMATION CONTACT: Christina A. Walsh at the above address, or by telephone (571) 227–2062. SUPPLEMENTARY INFORMATION: Comments Invited In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.), an agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a valid OMB control number. The ICR documentation will be available at http://www.reginfo.gov upon its submission to OMB. Therefore, in preparation for OMB review and approval of the following information collection, TSA is soliciting comments to— (1) Evaluate whether the proposed information requirement is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including using appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Information Collection Requirement OMB Control Number 1652–0044; Department of Homeland Security Traveler Redress Inquiry Program (DHS TRIP). DHS TRIP is a single point of contact for individuals who have inquiries or seek resolution regarding difficulties they have experienced during their travel screening. These difficulties could include: (1) Denied or E:\FR\FM\04JNN1.SGM 04JNN1

Agencies

[Federal Register Volume 86, Number 106 (Friday, June 4, 2021)]
[Notices]
[Pages 30063-30064]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11786]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2020-0016]


Meetings To Implement Pandemic Response Voluntary Agreement Under 
Section 708 of the Defense Production Act

AGENCY: Federal Emergency Management Agency, Department of Homeland 
Security.

ACTION: Announcement of meetings.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) held two 
meetings to implement the Voluntary Agreement for the Manufacture and 
Distribution of Critical Healthcare Resources Necessary to Respond to a 
Pandemic.

DATES: The first meeting took place on Tuesday, May 25, 2021, from 
10:30 a.m. to 12 p.m. Eastern Time (ET). The second meeting took place 
on Wednesday, May 26, 2021, from 2 to 3 p.m. ET.

FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, 
Industry, Infrastructure Integration, via email at [email protected] or 
via phone at (202) 212-1666.

SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as 
required by section 708(h)(8) of the Defense Production Act (DPA), 50 
U.S.C. 4558(h)(8), and consistent with 44 CFR part 332.
    The DPA authorizes the making of ``voluntary agreements and plans 
of action'' with representatives of industry, business, and other 
interests to help provide for the national defense.\1\ The President's 
authority to facilitate voluntary agreements with respect to responding 
to the spread of COVID-19 within the United States was delegated to the 
Secretary of Homeland Security in Executive Order 13911.\2\ The 
Secretary of Homeland Security further delegated this authority to the 
FEMA Administrator.\3\
---------------------------------------------------------------------------

    \1\ 50 U.S.C. 4558(c)(1).
    \2\ 85 FR 18403 (Apr. 1, 2020).
    \3\ DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS 
Delegation Number 09052 Rev. 00 (Jan. 3, 2017).
---------------------------------------------------------------------------

    On August 17, 2020, after the appropriate consultations with the 
Attorney General and the Chairman of the Federal Trade Commission, FEMA 
completed and published in the Federal Register a ``Voluntary 
Agreement, Manufacture and Distribution of Critical Healthcare 
Resources Necessary to

[[Page 30064]]

Respond to a Pandemic'' (Voluntary Agreement).\4\ Unless terminated 
earlier, the Voluntary Agreement is effective until August 17, 2025, 
and may be extended subject to additional approval by the Attorney 
General after consultation with the Chairman of the Federal Trade 
Commission. The Agreement may be used to prepare for or respond to any 
pandemic, including COVID-19, during that time.
---------------------------------------------------------------------------

    \4\ 85 FR 50035 (Aug. 17, 2020). The Attorney General, in 
consultation with the Chairman of the Federal Trade Commission, made 
the required finding that the purpose of the voluntary agreement may 
not reasonably be achieved through an agreement having less 
anticompetitive effects or without any voluntary agreement and 
published the finding in the Federal Register on the same day. 85 FR 
50049 (Aug. 17, 2020).
---------------------------------------------------------------------------

    On December 7, 2020, the first plan of action under the Voluntary 
Agreement--the Plan of Action to Establish a National Strategy for the 
Manufacture, Allocation, and Distribution of Personal Protective 
Equipment (PPE) to Respond to COVID-19 (Plan of Action)--was 
finalized.\5\ The Plan of Action established several sub-committees 
under the Voluntary Agreement, focusing on different aspects of the 
Plan of Action.
---------------------------------------------------------------------------

    \5\ See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 
8, 2020).
---------------------------------------------------------------------------

    The meetings were chaired by the FEMA Administrator or her delegate 
and attended by the Attorney General and the Chairman of the Federal 
Trade Commission or their delegates. In implementing the Voluntary 
Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 
4558 and 44 CFR part 332.
    Meeting Objectives: The objectives of the meetings were as follows:
    1. Gather committee Participants and Attendees to ask targeted 
questions for situational awareness about PPE, drug products and drug 
substances, diagnostic test kits, medical devices, and medical gases.
    2. Establish priorities for COVID-19 response under the Voluntary 
Agreement.
    3. Identify tasks that should be completed under the appropriate 
Sub-Committee.
    4. Identify information gaps and areas that merit sharing (both 
from FEMA to the private sector and vice versa).
    Meetings Closed to the Public: By default, the DPA requires 
meetings held to implement a voluntary agreement or plan of action be 
open to the public.\6\ However, attendance may be limited if the 
Sponsor \7\ of the voluntary agreement finds that the matter to be 
discussed at a meeting falls within the purview of matters described in 
5 U.S.C. 552b(c), such as trade secrets and commercial or financial 
information. The Sponsor of the Voluntary Agreement, the FEMA 
Administrator, found that these meetings to implement the Voluntary 
Agreement involved matters which fall within the purview of matters 
described in 5 U.S.C. 552b(c) and the meetings were therefore closed to 
the public.
---------------------------------------------------------------------------

    \6\ See 50 U.S.C. 4558(h)(7).
    \7\ ``[T]he individual designated by the President in subsection 
(c)(2) [of section 708 of the DPA] to administer the voluntary 
agreement, or plan of action.'' 50 U.S.C. 4558(h)(7).
---------------------------------------------------------------------------

    Specifically, these meetings to implement the Voluntary Agreement 
may have required participants to disclose trade secrets or commercial 
or financial information that is privileged or confidential. Disclosure 
of such information allows for meetings to be closed pursuant to 5 
U.S.C. 552b(c)(4). In addition, the success of the Voluntary Agreement 
depends wholly on the willing and enthusiastic participation of private 
sector participants. Failure to close these meetings could have had a 
strong chilling effect on private sector participation and caused a 
substantial risk that sensitive information would be prematurely 
released to the public, leading to participants withdrawing their 
support from the Voluntary Agreement. This would have significantly 
frustrated the implementation of the Voluntary Agreement. Frustration 
of an agency's objective due to premature disclosure of information 
allows for the closure of a meeting pursuant to 5 U.S.C. 552b(c)(9)(B).

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-11786 Filed 6-3-21; 8:45 am]
BILLING CODE 9111-19-P